Health Strategies Group has been the leader in market access market research for pharmaceutical and biotech professionals for more than 20 years. We provide a 360° view of how all stakeholders fit together to impact market access with custom and syndicated market research.
We help clients:
- Identify Barriers and Opportunities within the Access Landscape
- Develop Product Value Proposition for Market Access Stakeholders
- Optimize Distribution Strategy
- Improve Patient Access and Reimbursement Support
- Segment Accounts
- Build Productive Relationships with Market Access Stakeholders
- Develop Contracting Strategy
- Refine Programs and Resources for Market Access Stakeholders
From health plans to IDNs to ACOs, we transform syndicated and custom research results into practical knowledge and strategic recommendations so you can move confidently ahead.
Health Strategies Group
East Coast and West Coast offices
949-242-1035
www.healthstrategies.com/custom
LinkedIn: www.linkedin.com/company/health-strategies-group
Twitter: @HSGNews
Leadership:
Rod Cavin, Managing Director
Rayna Herman, Principal and SVP Sales and Marketing
Bob Shewbrooks, Principal and Syndicated Practice Leader
Denise Woltemath, VP Custom Research
New Business Contact:
Rayna Herman, Principal and SVP Sales and Marketing
rherman@healthstrategies.com
949-242-1035
What Makes Us Innovative:
As the importance and complexity of market access research has increased, we found an opportunity to build more sophisticated custom research offerings that provide clients the confidence to move ahead from pipeline to maturity.
Custom Access Insights brings an advanced set of global market access capabilities, frameworks and methods, plus our robust panel, to answer your specific market access questions across the product lifecycle from clinical development to loss of exclusivity.
- We provide a sophisticated method for predicting payer actions that goes beyond what respondents “say” they will do.
- We provide a specialized capability to develop future access scenarios.
- We develop frameworks to understand influencers and the capabilities of each so you have a 360° view of how stakeholders fit together to impact market access.
- We develop and nurture a robust panel including 23 of the top 25 health plans, leading ACOs and Health Systems, and access to 27,000 specialist physicians in the U.S. and a network of former payers, health technology appraisal (HTA) experts, and key market access stakeholders in the EU5 and select emerging markets.
